title: [The intensive therapy of multiple organ failure in myelotoxic agranulocytosis in a patient with acute leukemia].
authors.forename: E M
authors.initials: EM
authors.lastname: Shulutko
authors.forename: A V
authors.initials: AV
authors.lastname: Fedanov
authors.forename: I V
authors.initials: IV
authors.lastname: Tamarin
authors.forename: V G
authors.initials: VG
authors.lastname: Gorelov
authors.forename: A V
authors.initials: AV
authors.lastname: Pivnik
authors.forename: A M
authors.initials: AM
authors.lastname: Kremenetskaia
authors.forename: V M
authors.initials: VM
authors.lastname: Gorodetskiĭ
authors.forename: S V
authors.initials: SV
authors.lastname: Kozhurin
mesh_terms: D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced / Q000150:complications* / Q000628:therapy; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D001853:Bone Marrow / Q000187:drug effects*; D003422:Critical Care / Q000379:methods*; D003561:Cytarabine / Q000009:adverse effects; D003630:Daunorubicin / Q000009:adverse effects; D004211:Disseminated Intravascular Coagulation / Q000209:etiology / Q000628:therapy; D006801:Humans; D015479:Leukemia, Myelomonocytic, Acute / Q000150:complications* / Q000188:drug therapy; D008297:Male; D009102:Multiple Organ Failure / Q000209:etiology / Q000628:therapy*; D011014:Pneumonia / Q000209:etiology / Q000628:therapy; D012772:Shock, Septic / Q000209:etiology / Q000628:therapy; D013866:Thioguanine / Q000009:adverse effects; D013997:Time Factors
chemical_list: D003561:Cytarabine; D013866:Thioguanine; D003630:Daunorubicin
vernacular_title: Intensivnaia terapiia poliorgannoĭ nedostatochnosti pri mielotoksicheskom agranulotsitoze u bol'nogo ostrym leĭkozom.